Work

A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.7235

Authors: G. R. Simon, P. A. Janne, C. J. Langer, C. F. Verschraegen, A. Dowlati, S. M. Gadgeel, K. Kelly, L. Taylor, C. K. Obasaju, H. L. Kindler

Institutions: Fox Chase Cancer Center, Eli Lilly (United States), University of New Mexico, Wayne State University, Moffitt Cancer Center, University of Chicago, Dana-Farber Cancer Institute, Case Western Reserve University

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590400399

Cites:

Cited by: 2

Related to: 10